Beta-cell imaging: Call for evidence-based and scientific approach

Molecular Imaging and Biology

Volumn 15, Issue 2, 2013, Pages 123-130

  Blomberg, Björn A ^a   Codreanu, Ion ^b   Cheng, Gang ^b   Werner, Thomas J ^b   Alavi, Abass ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

DTBZ; Pancreas; PET; Cell mass

Indexed keywords

DIHYDROTETRABENAZINE; TRACER; VESICULAR MONOAMINE TRANSPORTER 2;

AUTORADIOGRAPHY; CELL DENSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MOLECULAR IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVIEW;

EID: 84878475135     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0620-4     Document Type: Review

References (65)

1. Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes 94:311-21
2. Golden SH (2011) Emerging therapeutic approaches for the management of diabetes mellitus and macrovascular complications. Am J Cardiol 108:59B-67B
3. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J et al (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes 87:293-301
4. von Herrath M, Chan A (2009) How can we improve the translational landscape for a faster cure of type 1 diabetes? J Clin Invest 119:1061-5
5. Matveyenko AV, Butler PC (2008) Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 10:23-31
6. Hanley NA, Hanley KP, Miettinen PJ, Otonkoski T (2008) Weighing up beta-cell mass in mice and humans: self-renewal, progenitors or stem cells? Mol Cell Endocrinol 288:79-85
7. de Kort H, de Koning EJ, Rabelink TJ, Bruijn JA, Bajema IM (2011) Islet transplantation in type 1 diabetes. BMJ 2011:d217
8. Goke B (2010) What are the potential benefits of clinical beta-cell imaging in diabetes mellitus? Curr Pharm Des 16:1547-9
9. Ichise M, Harris PE (2010) Imaging of beta-cell mass and function. J Nucl Med 51:1001-4
10. Wu Z, Kandeel F (2010) Radionuclide probes for molecular imaging of pancreatic beta-cells. Adv Drug Deliv Rev 62:1125-38
11. Brom M, Andralojc K, Oyen WJ, Boerman OC, Gotthardt M (2010) Development of radiotracers for the determination of the beta-cell mass in vivo Curr Pharm Des 16:1561-7
12. Schneider S (2008) Efforts to develop methods for in vivo evaluation of the native beta-cell mass. Diabetes Obes Metab 10:109-18
13. Blomberg BA, Moghbel MC, Saboury B, Stanley CA, Alavi A (2012) The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol. doi: 10.1007/s11307-012-0572-0
14. Hardy OT, Hernandez-Pampaloni M, Saffer JR, Scheuermann JS, Ernst LM, Freifelder R et al (2007) Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. J Clin Endocrinol Metab 92:4706-11. doi: 10.1210/jc.2007-1637
15. Hardy OT, Hernandez-Pampaloni M, Saffer JR, Suchi M, Ruchelli E, Zhuang H et al (2007) Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr 150:140-5. doi: 10.1016/j.jpeds.2006.08.028
16. Schmitz A, Shiue CY, Feng Q, Shiue GG, Deng S, Pourdehnad MT et al (2004) Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents. Nucl Med Biol 31:483-91. doi: 10.1016/j.nucmedbio.2003.12.003
17. Schneider S, Feilen PJ, Schreckenberger M, Schwanstecher M, Schwanstecher C, Buchholz HG et al (2005) In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. Exp Clin Endocrinol Diabetes 113:388-95. doi: 10.1055/s-2005-865711
18. Wangler B, Beck C, Shiue CY, Schneider S, Schwanstecher C, Schwanstecher M et al (2004) Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3- methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent. Bioorg Med Chem Lett 14:5205-9. doi: 10.1016/j.bmcl.2004.07.059
19. Wangler B, Schneider S, Thews O, Schirrmacher E, Comagic S, Feilen P et al (2004) Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl- 1-(2-piperidin-1-yl-phenyl)-butyl-carbam oyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET). Nucl Med Biol 31:639-47. doi: 10.1016/j.nucmedbio.2004.01.007
20. Souza F, Simpson N, Raffo A, Saxena C, Maffei A, Hardy M et al (2006) Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest 116:1506-13
21. Simpson NR, Souza F, Witkowski P, Maffei A, Raffo A, Herron A et al (2006) Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol 33:855-64
22. Goland R, Freeby M, Parsey R, Saisho Y, Kumar D, Simpson N et al (2009) 11C-Dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 50:382-9
23. Normandin MD, Petersen KF, Ding YS, Lin SF, Naik S, Fowles K et al (2012) In vivo imaging of endogenous pancreatic beta-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET. J Nucl Med 53:908-16
24. Kung HF, Lieberman BP, Zhuang ZP, Oya S, Kung MP, Choi SR et al (2008) In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine. Nucl Med Biol 35:825-37
25. Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E et al (2008) In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. J Nucl Med 49:1171-6
26. Singhal T, Ding YS, Weinzimmer D, Normandin MD, Labaree D, Ropchan J et al (2011) Pancreatic beta cell mass PET imaging and quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in rodent models of diabetes. Mol Imaging Biol 13:973-84
27. Anlauf M, Eissele R, Schafer MK, Eiden LE, Arnold R, Pauser U et al (2003) Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J Histochem Cytochem 51:1027-40
28. Robertson RP (2007) Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? Diabetes 56:2420-4
29. Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K et al (2003) Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 61:310-5
30. Koeppe RA, Frey KA, Vander Borght TM, Karlamangla A, Jewett DM, Lee LC et al (1996) Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter. J Cereb Blood Flow Metab 16:1288-99
31. Chan GL, Holden JE, Stoessl AJ, Samii A, Doudet DJ, Dobko T et al (1999) Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects. J Nucl Med 40:283-9
32. Eriksson O, Jahan M, Johnstrom P, Korsgren O, Sundin A, Halldin C, Eriksson O, Jahan M, Johnstrom P, Korsgren O, Sundin A, Halldin C et al (2010) In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass. Nucl Med Biol 37:357-63
33. Tsao HH, Lin KJ, Juang JH, Skovronsky DM, Yen TC, Wey SP et al (2010) Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats. Nucl Med Biol 37:413-9
34. Lin KJ, Weng YH, Wey SP, Hsiao IT, Lu CS, Skovronsky D et al (2010) Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent. J Nucl Med 51:1480-5
35. Veluthakal R, Harris P (2010) In vivo beta-cell imaging with VMAT 2 ligands - current state-of-the-art and future perspective. Curr Pharm Des 16:1568-81
36. Saisho Y, Harris PE, Butler AE, Galasso R, Gurlo T, Rizza RA et al (2008) Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol 39:543-51
37. Philippe MF, Benabadji S, Barbot-Trystram L, Vadrot D, Boitard C, Larger E (2011) Pancreatic volume and endocrine and exocrine functions in patients with diabetes. Pancreas 40:359-63. doi: 10.1097/MPA.0b013e3182072032
38. el Newihi H, Dooley CP, Saad C, Staples J, Zeidler A, Valenzuela JE (1988) Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig Dis Sci 33:705-10
39. Foulis AK, Stewart JA (1984) The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 26:456-61
40. Williams AJ, Chau W, Callaway MP, Dayan CM (2007) Magnetic resonance imaging: a reliable method for measuring pancreatic volume in type 1 diabetes. Diabet Med 24:35-40. doi: 10.1111/j.1464-5491.2007.02027.x
41. Basu S, Alavi A (2007) Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? Eur J Nucl Med Mol Imaging 34:1527-9. doi: 10.1007/s00259-007-0467-5
42. Basu S, Zaidi H, Houseni M, Bural G, Udupa J, Acton P et al (2007) Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. Semin Nucl Med 37:223-39
43. Chawluk JB, Alavi A, Dann R, Hurtig HI, Bais S, Kushner MJ et al (1987) Positron emission tomography in aging and dementia: effect of cerebral atrophy. J Nucl Med 28:431-7
44. Hickeson M, Yun M, Matthies A, Zhuang H, Adam LE, Lacorte L et al (2002) Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging 29:1639-47
45. Srinivas SM, Dhurairaj T, Basu S, Bural G, Surti S, Alavi A (2009) A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med 23:341-8. doi: 10.1007/s12149-009-0241-9
46. Tanna NK, Kohn MI, Horwich DN, Jolles PR, Zimmerman RA, Alves WM et al (1991) Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. Radiology 178:123-30
47. Goriya Y, Hoshi M, Etani N, Kimura K, Shichiri M (1975) Dynamic study of exocrine function of the pancreas in diabetes mellitus with scintigraphy using 75Se-selenomethionine. J Nucl Med 16:270-4
48. Di Gialleonardo V, Signore A, Scheerstra EA, Visser AK, van Waarde A, Dierckx RA et al (2012) 11C-Hydroxytryptophan uptake and metabolism in endocrine and exocrine pancreas. J Nucl Med 53:1755-63. doi: 10.2967/jnumed.112.104117
49. Otsuki K, Yoshikawa K, Kenmochi T, Saigo K, Maruyama M, Akutsu N et al (2010) Evaluation of pancreatic function in normal pancreas as living-related donors and type 1 diabetic pancreas as recipients for pancreas transplantation using 11c-methionine positron emission tomography. Pancreas 39:418-9. doi: 10.1097/MPA.0b013e3181bb90d7
50. Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W et al (2006) 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med 47:904-11
51. Patel R, Atherton P, Wackerhage H, Singh J (2006) Signaling proteins associated with diabetic-induced exocrine pancreatic insufficiency in rats. Ann N Y Acad Sci 1084:490-502. doi: 10.1196/annals.1372.026
52. Sweet IR, Cook DL, Lernmark A, Greenbaum CJ, Krohn KA (2004) Non-invasive imaging of beta cell mass: a quantitative analysis. Diabetes Technol Ther 6:652-9
53. Sweet IR, Cook DL, Lernmark A, Greenbaum CJ, Wallen AR, Marcum ES et al (2004) Systematic screening of potential beta-cell imaging agents. Biochem Biophys Res Commun 314:976-83
54. Kessler RM, Ellis JR Jr, Eden M (1984) Analysis of emission tomographic scan data: limitations imposed by resolution and background. J Comput Assist Tomogr 8:514-22
55. Bosco D, Armanet M, Morel P, Niclauss N, Sgroi A, Muller YD et al (2010) Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 59:1202-10
56. Sanchez-Crespo A, Andreo P, Larsson SA (2004) Positron flight in human tissues and its influence on PET image spatial resolution. Eur J Nucl Med Mol Imaging 31:44-51
57. Kwee TC, Basu S, Saboury B, Torigian DA, Naji A, Alavi A (2011) Beta-cell imaging: opportunities and limitations. J Nucl Med 52:493, author reply 5
58. Cline GW, Zhao X, Jakowski AB, Soeller WC, Treadway JL (2011) Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic beta-cell mass. Biochem Biophys Res Commun 412:413-8
59. Heidari Z, Mahmoudzadeh-Sagheb H, Moudi B (2008) A quantitative study of sodium tungstate protective effect on pancreatic beta cells in streptozotocin-induced diabetic rats. Micron 39:1300-5
60. Virostko J, Henske J, Vinet L, Lamprianou S, Dai C, Radhika A et al (2011) Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci U S A 108:20719-24
61. Tsao HH, Skovronsky DM, Lin KJ, Yen TC, Wey SP, Kung MP (2011) Sigma receptor binding of tetrabenazine series tracers targeting VMAT2 in rat pancreas. Nucl Med Biol 38:1029-34
62. Fagerholm V, Mikkola KK, Ishizu T, Arponen E, Kauhanen S, Nagren K et al (2010) Assessment of islet specificity of dihydrotetrabenazine radiotracer binding in rat pancreas and human pancreas. J Nucl Med 51:1439-46
63. Blomberg BA, Eriksson O, Saboury B, Alavi A (2012) beta-Cell mass imaging with DTBZ positron emission tomography: is it possible? Mol Imaging Biol. doi: 10.1007/s11307-012-0593-8
64. Blomberg BA, Moghbel MC, Alavi A (2012) PET imaging of beta-cell mass: is it feasible? Diabetes Metab Res Rev 28:601-2. doi: 10.1002/dmrr.2314
65. Eriksson O, Alavi A (2012) Imaging the islet graft by positron emission tomography. Eur J Nucl Med Mol Imaging 39:533-42. doi: 10.1007/s00259-011-1928-4